Today's Highlights
Premium
Incyte Drug Baricitinib Has Promising Results in Rheumatoid Arthritis and More News
In December 2009, Lilly (LLY) and Incyte (INCY) announced an exclusive worldwide license and collaboration agreement for the development and commercialization ofbaricitinib and certain follow-on compo...
P
Prohost Biotech
1 min read
3
0
Unlock Premium Content
This article contains exclusive content for our premium subscribers. Join our community to access in-depth research, expert insights, and comprehensive analysis.
Unlimited articles
Expert analysis
Research reports
Tags
Agenus (AGEN)
Alnylam Pharmaceuticals (ALNY)
Amgen (AMGN)
BioCryst Pharmaceuticals (BCRX)
Cellceutix Corporation (CTIX)
Eli Lilly (LLY)
Gilead Sciences (GILD)
Halozyme Therapeutics (HALO)
Illumina (ILMN)
ImmunoGen (IMGN)
Incyte (INCY)
Ionis Pharmaceuticals Inc (IONS)
Jazz Pharmaceuticals (JAZZ)
Nektar Therapeutics (NKTR)
Pharmacyclics (PCYC)
Portola Pharmaceuticals Inc (PTLA)
PTC Therapeutics (PTCT)
Regulus Pharmaceuticals (RGLS)
Sangamo Therapeutics Inc (SGMO)
Seagen Inc (SGEN)
Sequenom (SQNM)
Tekmira Pharmaceuticals Corp (TKMR)
Theravance Biopharma (TBPH)
Theravance Inc (THRX)
Vertex Pharmaceuticals (VRTX)
Xoma (XOMA)
Comments (0)
Please sign in to join the discussion